Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|26|6|522-527

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.26, Iss.6, 2008-12, pp. : 522-527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galantamine for Alzheimer’s Disease and Mild Cognitive Impairment

By  

Neuroepidemiology, Vol. 28, Iss. 2, 2007-04 ,pp. : 116-117

Karger

Access to resources Recommend Favorite

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-11 ,pp. : 393-401

Karger

Access to resources Recommend Favorite

Anosognosia in Very Mild Alzheimer’s Disease but Not in Mild Cognitive Impairment

By  

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 5-6, 2005-04 ,pp. : 349-356

Karger

Access to resources Recommend Favorite

Increased Serum IL-1β Level in Alzheimer’s Disease and Mild Cognitive Impairment

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 6, 2009-12 ,pp. : 507-512

Karger

Access to resources Recommend Favorite

Cognitive Profiles in Alzheimer’s Disease and in Mild Cognitive Impairment of Different Etiologies

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 5-6, 2006-05 ,pp. : 309-315

Karger

Access to resources Recommend Favorite